Actionable news
0
All posts from Actionable news
Actionable news in HLF: HERBALIFE Ltd.,

Pivotal's Ramey Pounds Table On Herbalife

Herbalife LTD. NYSE:HLF - Pivotal's Ramey Pounds Table On Herbalife

Pivotal Research analyst Tim Ramey, who has a Buy rating on Herbalife Ltd. (NYSE: HLF) shares, maintains that the company would have injunction or consent decree as part of its potential settlement with FTC.

"We clearly are moving forward to something …it could be litigation we can take that off the table," Ramey told CNBC.

Related Link: Herbalife's Bullish Trifecta: Beat, Raise And FTC Disclosure Making Investors Happy

Ramey says shorting the stock is "absurdly risky" and his $90 price target implies an upside of 54 percent from Thursday's close.

Herbalife reported first-quarter EPS of $1.36 versus $1.09 estimates and revenue of $1.11 billion versus $1.07 estimates. The company raised its FY2016 adjusted EPS guidance to a range of $4.40 to $4.75, from $4.05 to $4.50 previously.

Ramey added that the "fundamentals [were] still very strong."

DateFirmActionFromTo
Apr 2016BarclaysTerminatesOverweightOve
Aug 2015Pivotal ResearchMaintainsBuy
May 2015Canaccord GenuityMaintainsBuy

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.